| |
|
|
|
ENDRA Life Sciences Inc.  
|
|
0.8886 -0.02 (-0.02%) |
07-10 16:00 |
|
Open: |
0.909 |
Pre close: |
0.909 |
Target:
|
1.20
|
|
High: |
0.909 |
Low: |
0.88 |
Resistance:
|
1.03
1.17
|
|
Volume: |
189,060 |
Market Cap: |
13M |
Support:
|
0.81
0.67
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.90
 |
MACD |
MACD(12,26):
|
0.00 |
|
MA(20): |
0.96  |
Signal(12,26,9): |
0.02 |
|
MA(100): |
0.88 |
Stochastic Oscillator |
%K(14,3):
|
17.98 |
|
MA(250): |
1.16 |
%D(3): |
18.88 |
|
Average Volume(K) |
3-Month: |
43498
|
52-Week |
High:
|
2.25 |
|
10-Days: |
73556 |
Low: |
0.60 |
|
RSI |
RSI(14):
|
45.50 |
Change(%): |
-41.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.124 |
Return on Equity (ttm) |
-439.0 |
Shares Out. (M) |
14.50 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-154.9 |
Shares Float (M) |
12.68 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.45 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
8.87 |
|
Forward EPS |
-2.170 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
620 |
|
Book Value (p.s.) |
0.190 |
EBITDA (p.s.) |
-0.766 |
P/E |
-0.42 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.68 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-9.14 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-3.96 |
P/CF |
-1.41 |
|
|
|
|
|
|
